Skip to content

Zirconia Reinforced Glass Ionomer in MIH

Effectiveness Of Zirconia Reinforced Glass Ionomer Used In Alternative Restorative Treatment In Molar Incisor Hypomineralization (A Randomized Controlled Clinical Trial And Finite Element Analysis)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05494749
Enrollment
88
Registered
2022-08-10
Start date
2022-09-01
Completion date
2023-12-30
Last updated
2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Molar Incisor Hypomineralization

Brief summary

Molar-incisor hypomineralization (MIH) is a qualitative enamel defect, in which molars and incisors involved are prone to post-eruptive enamel breakdown leading to sensitivity, and caries. Atraumatic/Alternative Restorative Treatment (ART) is a minimally invasive procedure. It can be very beneficial in managing MIH-affected molars in communities with limited access to dental care. Zirconia-reinforced GI was recently introduced. It is claimed to serve as a long-term temporary restoration until a more permanent restoration is placed

Interventions

teeth meeting the inclusion criteria are assigned to receive Zirconomer® restorations

OTHERHVGI-Equia Forte

teeth meeting the inclusion criteria are assigned to receive HVGI-Equia Forte® restorations.

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* Children free from any systemic disease (ASA I). * Cooperative children showing positive or definitely positive behavior according to Frankl rating scale * Hypomineralized first permanent molars that are restorable according to MIH Treatment Need Index (MIH-TNI): Index (2a), (2b), (4a), (4b) * Teeth with dentinal lesions corresponding to ICDAS II score 5 or 6 * No clinical or radiographic evidence of pulpal involvement.

Exclusion criteria

* Index (0), (1), (2c), (3), (4c) on the MIH Treatment Need Index. * Patients whose parents will not give their consent to participate in the study * Non-restorable first permanent molars indicated for extraction

Design outcomes

Primary

MeasureTime frameDescription
Change in clinical success rateat 3 months, 6 months, 9 months, 12 monthsIt will be assessed using Modified ART criteria, restorations receiving a score of: (0) Restoration is present and satisfactory OR (1) Restoration is present, slight defect at the cavity margin of less than 0.5 mm; no repair is needed. will be considered successful, and any other score will be considered a failure.

Secondary

MeasureTime frameDescription
Change in painat 1 week, 3 months, 6 months, 9 months, 12 monthsPain will be recorded using VAS Using a visual analog scale (VAS), the subjects were instructed how to point to the position of the line between faces to indicate how much painthey might feel. In this system, the total scores range from 0 to 100 based on measuring the distance in millimeters from the left end bar to the mark made by the child on the 10 cm line anchored by happy to sad faces, with a higher score indicating more severe pain.
Change in sensitivityat 1 week, 3 months, 6 months, 9 months, 12 monthssensitivity will be recorded using VAS by performing air blast test Using a visual analog scale (VAS), the subjects were instructed how to point to the position of the line between faces to indicate how much pain they might feel. In this system, the total scores range from 0 to 100 based on measuring the distance in millimeters from the left end bar to the mark made by the child on the 10 cm line anchored by happy to sad faces, with a higher score indicating more severe pain.
Finite element analysis12 monthsPerformance of both Zirconomer and HVGI-Equia Forte under dynamic occlusal loads will be assessed using Finite Element Analysis using ANSYS software.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026